0.00
price down icon100.00%   -0.0941
 
loading
전일 마감가:
$0.0941
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$5.67M
수익:
$7.10M
순이익/손실:
$-31.59M
주가수익비율:
0.00
EPS:
-2.61
순현금흐름:
$-26.75M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
Value
$0.00
$0.00
1주일 범위
Value
$0.00
$0.00
52주 변동 폭
Value
$0.00
$1.72

Palatin Technologies Inc. Stock (PTN) Company Profile

Name
명칭
Palatin Technologies Inc.
Name
전화
609-495-2200
Name
주소
Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ
Name
직원
19
Name
트위터
@PalatinTech
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
PTN's Discussions on Twitter

PTN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PTN
Palatin Technologies Inc.
0.00 5.67M 7.10M -31.59M -26.75M -2.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.68 99.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.73 62.21B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.61 59.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
703.64 43.34B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.23 36.72B 3.81B -644.79M -669.77M -6.24

Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2015-06-05 재확인 Canaccord Genuity Buy
2015-01-12 재확인 ROTH Capital Buy
2012-05-23 개시 Noble Financial Buy
2007-01-23 개시 Next Generation Buy

Palatin Technologies Inc. 주식(PTN)의 최신 뉴스

pulisher
Aug 19, 2025

Palatin Technologies Trades At A Discount As Risks Stack Up - Finimize

Aug 19, 2025
pulisher
Aug 19, 2025

Boehringer Expands Eyecare Horizons With Palatin Collaboration - insights.citeline.com

Aug 19, 2025
pulisher
Aug 19, 2025

Boehringer Ingelheim, Palatin Technologies to develop melanocortin receptor targeted treatment for... - Medical Dialogues

Aug 19, 2025
pulisher
Aug 18, 2025

Palatin Technologies, Inc. (AMEX:PTN) Q3 2025 Earnings Call Transcript - MSN

Aug 18, 2025
pulisher
Aug 18, 2025

Boehringer and Palatin team up on retinal diseases research - The Pharma Letter

Aug 18, 2025
pulisher
Aug 18, 2025

Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases - The Manila Times

Aug 18, 2025
pulisher
Aug 18, 2025

Boehringer Ingelheim and Palatin Technologies to develop - GlobeNewswire

Aug 18, 2025
pulisher
Aug 18, 2025

Boehringer Ingelheim Limited - Via Ritzau

Aug 18, 2025
pulisher
Aug 18, 2025

Boehringer Ingelheim and Palatin Technologies, Inc. to Develop Potential First-In-Class Melanocortin Receptor Targeted Treatment for Patients with Retinal Diseases - MarketScreener

Aug 18, 2025
pulisher
Aug 14, 2025

Palatin Technologies (PTNT) Stock Price, News & Analysis - MarketBeat

Aug 14, 2025
pulisher
Aug 09, 2025

Palantin Technologies to enact 1-for-50 reverse stock split - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Palantin Technologies Implements Reverse Stock Split to Meet NYSE Listing Requirements - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

Palatin Technologies announces 1-for-50 reverse stock split - Investing.com India

Aug 09, 2025
pulisher
Aug 08, 2025

Palatin Announces 1-for-50 Reverse Stock Split - The Malaysian Reserve

Aug 08, 2025
pulisher
Aug 08, 2025

Palatin Technologies announces 1-for-50 reverse stock split By Investing.com - Investing.com Nigeria

Aug 08, 2025
pulisher
Aug 08, 2025

Palatin Announces 1-For-50 Reverse Stock Split - Barchart.com

Aug 08, 2025
pulisher
Jul 29, 2025

Palatin Technologies Stockholders Approve Key Governance Changes - TipRanks

Jul 29, 2025
pulisher
Jul 29, 2025

Palatin Technologies shareholders approve reverse stock split and board elections - Investing.com

Jul 29, 2025
pulisher
Jul 24, 2025

Palatin Reports Fiscal Year 2025 Third Quarter Results and Business Update - ADVFN Brasil

Jul 24, 2025
pulisher
Jul 24, 2025

Why This French Biotech Stock Just Soared 586% In One Day - Barchart.com

Jul 24, 2025
pulisher
Jul 16, 2025

Palatin Technologies reports efficacy of PL-7737 in obesity model - BioWorld MedTech

Jul 16, 2025
pulisher
Jul 16, 2025

Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity - The Malaysian Reserve

Jul 16, 2025
pulisher
Jul 15, 2025

Palatin announces positive preclinical efficacy data for oral MC4R agonist PL7737 in animal model of obesity - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Breakthrough Oral Weight Loss Drug Achieves 15% Reduction When Combined with Tirzepatide in Just 4 Days - Stock Titan

Jul 15, 2025
pulisher
Jul 09, 2025

Palatin Technologies receives NYSE American delisting notice, appeals decision By Investing.com - Investing.com Nigeria

Jul 09, 2025
pulisher
Jul 09, 2025

Palatin Technologies receives NYSE American delisting notice, appeals decision - Investing.com Australia

Jul 09, 2025
pulisher
Jun 20, 2025

Palatin Technologies Announces Closing of Reduced Public Offering (PR Newswire) - Aktiellt

Jun 20, 2025
pulisher
Jun 17, 2025

Palatin Technologies Executives Make Massive Stock Purchases! - TipRanks

Jun 17, 2025
pulisher
Jun 13, 2025

Palatin Technologies Raises $340K in Private Placement - TipRanks

Jun 13, 2025
pulisher
Jun 09, 2025

Palatin Technologies, Inc. announced that it expects to receive $0.34 million in funding - MarketScreener

Jun 09, 2025
pulisher
May 27, 2025

Palatin Technologies (PALI) Teams Up with Key Managers for Inves - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Palatin Technologies (PALI) Teams Up with Key Managers for Investment Strategy | PALI Stock News - GuruFocus

May 27, 2025
pulisher
May 20, 2025

Palatin Technologies (NYSE:PTN) Coverage Initiated by Analysts at StockNews.com - Defense World

May 20, 2025
pulisher
May 15, 2025

Moderate Dry Eye Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | mc2 therapeutics, Palatin Technologies, Novaliq - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

Palatin Technologies Inc (PTNT) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Palatin Technologies Inc (PTNT) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Earnings call transcript: Palatin’s Q3 FY2025 shows narrower loss By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

Earnings call transcript: Palatin’s Q3 FY2025 shows narrower loss - Investing.com Australia

May 14, 2025
pulisher
May 14, 2025

Palatin Technologies Q1 Net Loss Narrows On Lower Expenses - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Palatin Technologies (PTN) to Release Quarterly Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 13, 2025

Palatin Technologies director Robert DeVeer buys $10,180 in stock By Investing.com - Investing.com UK

May 13, 2025
pulisher
May 12, 2025

Palatin Technologies director Robert DeVeer buys $10,180 in stock - Investing.com

May 12, 2025
pulisher
May 10, 2025

Palatin reveals potential diabetic retinopathy treatments - Investing.com

May 10, 2025

Palatin Technologies Inc. (PTN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$25.09
price up icon 1.21%
$84.09
price down icon 0.61%
$25.20
price up icon 1.91%
$102.39
price down icon 0.60%
$136.15
price up icon 0.89%
biotechnology ONC
$299.30
price down icon 0.28%
자본화:     |  볼륨(24시간):